It's a Wrap: Pharmaceutical-Biotech-Life Science Sector Completes $5.5 Billion in Capital/MRO Construction in First-Quarter 2015

SUGAR LAND--February 17, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--By the time the first quarter of 2015 ends, the North American Pharmaceutical & Biotech Industry is expected to wrap up more than $5.5 billion worth of capital and maintenance investments, according to Industrial Info's project database. Spread over 272 individual projects, this figure covers all those scheduled for completion from January 1, 2015, through March 31, 2015. While some of the smaller projects began construction rather recently, others kicked off several years ago.

Within this article: Details on key projects from major companies, including Unipharma LLC and Hoffman-LaRoche's Genentech, and George Washington University.